TR200601379T1 - Rosiglitazon maleat polimorflarının üretilmesine mahsus işlem. - Google Patents

Rosiglitazon maleat polimorflarının üretilmesine mahsus işlem.

Info

Publication number
TR200601379T1
TR200601379T1 TR2006/01379T TR200601379T TR200601379T1 TR 200601379 T1 TR200601379 T1 TR 200601379T1 TR 2006/01379 T TR2006/01379 T TR 2006/01379T TR 200601379 T TR200601379 T TR 200601379T TR 200601379 T1 TR200601379 T1 TR 200601379T1
Authority
TR
Turkey
Prior art keywords
production
rosiglitazone maleate
rosiglitazone
polymorphs
maleate polymorphs
Prior art date
Application number
TR2006/01379T
Other languages
English (en)
Inventor
Narayanrao Kankan Rajendra
Ramachandra Rao Dharmaraj
Singh Phull Manjinder
Ramdas Brari Dilip
Original Assignee
Cipla Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd. filed Critical Cipla Ltd.
Publication of TR200601379T1 publication Critical patent/TR200601379T1/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bu buluş, rosiglitazonun hazırlanması için işlemlere, bu işlemler ile hazırlanan rosiglitazona ve rosiglitazonun farmasötik bileşimleri ve bu farmasötik bileşimlerin terapötik kullanımlarına ve bu bileşimler kullanılan tedavi usullerine ilişkindir.
TR2006/01379T 2003-08-29 2004-08-13 Rosiglitazon maleat polimorflarının üretilmesine mahsus işlem. TR200601379T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0320304A GB2405403A (en) 2003-08-29 2003-08-29 Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base

Publications (1)

Publication Number Publication Date
TR200601379T1 true TR200601379T1 (tr) 2007-01-22

Family

ID=28686590

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2006/01379T TR200601379T1 (tr) 2003-08-29 2004-08-13 Rosiglitazon maleat polimorflarının üretilmesine mahsus işlem.

Country Status (9)

Country Link
US (1) US7678916B2 (tr)
KR (1) KR101145433B1 (tr)
AU (1) AU2004268816B2 (tr)
CA (1) CA2536784A1 (tr)
DE (1) DE112004001572T5 (tr)
GB (2) GB2405403A (tr)
RU (1) RU2342385C2 (tr)
TR (1) TR200601379T1 (tr)
WO (1) WO2005021541A2 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
CZ297266B6 (cs) * 2004-09-10 2006-10-11 Zentiva, A. S. Zpusob prípravy rosiglitazonu
WO2009104200A1 (en) * 2008-02-21 2009-08-27 Biocon Limited A method for preparation of thiazolidinedione derivatives
EP2184055A1 (en) * 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
WO1997027191A1 (en) * 1996-06-19 1997-07-31 Dr. Reddy's Research Foundation Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6602291B1 (en) * 1999-04-05 2003-08-05 Raymedica, Inc. Prosthetic spinal disc nucleus having a shape change characteristic
MXPA01010822A (es) * 1999-04-23 2002-06-04 Smithkline Beecham Plc Composicion farmaceutica novedosa.
DZ3155A1 (fr) * 1999-04-23 2000-11-02 Smithkline Beecham Plc Nouvelle composition pharmaceutique.
CO5170421A1 (es) * 1999-04-23 2002-06-27 Smithkline Beecham Plc Nuevo compuesto farmaceutico maleico
US7060100B2 (en) * 1999-10-08 2006-06-13 Ferree Bret A Artificial disc and joint replacements with modular cushioning components
AU9123201A (en) * 2000-09-26 2002-04-08 Reddy S Res Foundation Novel polymorphic forms of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione maleate and process for their preparation
US6733533B1 (en) * 2002-11-19 2004-05-11 Zimmer Technology, Inc. Artificial spinal disc
WO2004062667A1 (en) * 2003-01-08 2004-07-29 Dr. Reddy's Laboratories Limited Amorphous form of rosiglitazone maleate and process for preparation thereof
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
US6893465B2 (en) * 2003-03-31 2005-05-17 Shi, Tain-Yew Vividly simulated prosthetic intervertebral disc
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate

Also Published As

Publication number Publication date
WO2005021541A2 (en) 2005-03-10
DE112004001572T5 (de) 2006-07-06
AU2004268816A1 (en) 2005-03-10
GB2421504B (en) 2008-12-03
GB2405403A (en) 2005-03-02
GB0606312D0 (en) 2006-05-10
GB0320304D0 (en) 2003-10-01
CA2536784A1 (en) 2005-03-10
KR101145433B1 (ko) 2012-05-16
GB2421504A (en) 2006-06-28
RU2342385C2 (ru) 2008-12-27
US20060264639A1 (en) 2006-11-23
US7678916B2 (en) 2010-03-16
WO2005021541A3 (en) 2005-05-06
AU2004268816B2 (en) 2011-04-14
KR20070027483A (ko) 2007-03-09
RU2006110040A (ru) 2007-10-10

Similar Documents

Publication Publication Date Title
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
CY1112495T1 (el) Κυτταροτοξικοι παραγοντες που περιλαμβανουν νεα παραγωγα τομαϋμυκινης
TNSN05194A1 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200606162A (en) Pyrazolopyridine derivatives
TW200616979A (en) Non-nucleoside reverse transcriptase inhibitors
NO20075624L (no) Nye histamin H3-reseptorligander og deres terapeutiske anvendelser
DE602004015810D1 (de) Substituierte isochinolinderivate und anwendungsverfahren
ATE440087T1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
CY1110115T1 (el) Παραγωγα ακετυλενυλο-πυραζολο-πυριμιδινης ως mglur2 ανταγωνιστες
ATE432260T1 (de) Pyridinderivate als pkc-theta-hemmer
ES2368594T3 (es) Derivados sustituidos de ciclohexilmetilo.
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
NO20061363L (no) Pyrazolo- og imidazo- pyrimidinderivater
SE0401762D0 (sv) Novel compounds
DK1730147T3 (da) Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser til behandling af fedme
CY1109808T1 (el) Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
BRPI0411294A (pt) derivados de amino-propanol
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
ATE438617T1 (de) Substituierte cyclohexyl-1,4-diamin-derivate
NO20063611L (no) Fremgangsmater for fremstilling av aryl- og heteroarylsulfonylhalider
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
NO20083201L (no) Nye fenantridinderivater som bradykininantagonister
EA200501310A1 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения боли